Literature DB >> 16084405

Role of epidermal growth factor in the pathogenesis of neonatal necrotizing enterocolitis.

Brad W Warner1, Barbara B Warner.   

Abstract

Neonatal necrotizing enterocolitis (NEC) is an increasingly frequent condition encountered in premature infants for which the etiology is not well understood. Epidermal growth factor (EGF) is abundant in many fluids bathing the fetal and neonatal gastrointestinal tract, including amniotic fluid, saliva, and breast milk. EGF is acknowledged to be important for normal intestinal development as well as repair following injury to the gastrointestinal mucosa. There appears to be mounting evidence to support a possible link between deficient EGF production and the development of NEC. The relevant evidence for the role of EGF in intestinal development and mucosal repair, as well as its potential involvement in the genesis of NEC will be reviewed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16084405     DOI: 10.1053/j.sempedsurg.2005.05.006

Source DB:  PubMed          Journal:  Semin Pediatr Surg        ISSN: 1055-8586            Impact factor:   2.754


  16 in total

1.  Epidermal growth factor reduces autophagy in intestinal epithelium and in the rat model of necrotizing enterocolitis.

Authors:  Andrew A Maynard; Katerina Dvorak; Ludmila Khailova; Holly Dobrenen; Kelly M Arganbright; Melissa D Halpern; Ashish R Kurundkar; Akhil Maheshwari; Bohuslav Dvorak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-10       Impact factor: 4.052

Review 2.  Necrotizing enterocolitis in newborns: pathogenesis, prevention and management.

Authors:  Alecia M Thompson; Matthew J Bizzarro
Journal:  Drugs       Date:  2008       Impact factor: 9.546

3.  Increased expression and internalization of the endotoxin coreceptor CD14 in enterocytes occur as an early event in the development of experimental necrotizing enterocolitis.

Authors:  Kevin P Mollen; Steven C Gribar; Rahul J Anand; David J Kaczorowski; Jeffrey W Kohler; Maria F Branca; Theresa D Dubowski; Chhinder P Sodhi; David J Hackam
Journal:  J Pediatr Surg       Date:  2008-06       Impact factor: 2.545

4.  Bacterial DNA content in the intestinal wall from infants with necrotizing enterocolitis.

Authors:  Brian T Bucher; Lucas A McDuffie; Nurmohammad Shaikh; Phillip I Tarr; Barbara B Warner; Aaron Hamvas; Frances V White; Christopher R Erwin; Brad W Warner
Journal:  J Pediatr Surg       Date:  2011-06       Impact factor: 2.545

5.  P-glycoprotein induction by breast milk attenuates intestinal inflammation in experimental necrotizing enterocolitis.

Authors:  Yigit S Guner; Ashanti L Franklin; Nikunj K Chokshi; Shannon L Castle; Elizabeth Pontarelli; Jin Wang; Larry Wang; Nemani V Prasadarao; Jeffrey S Upperman; Anatoly V Grishin; Henri R Ford
Journal:  Lab Invest       Date:  2011-07-25       Impact factor: 5.662

Review 6.  The development of animal models for the study of necrotizing enterocolitis.

Authors:  Chhinder Sodhi; Ward Richardson; Steven Gribar; David J Hackam
Journal:  Dis Model Mech       Date:  2008 Sep-Oct       Impact factor: 5.758

7.  Low levels of procalcitonin during episodes of necrotizing enterocolitis.

Authors:  Dan Turner; Cathy Hammerman; Bernard Rudensky; Yechiel Schlesinger; Eytan Wine; Aleixo Muise; Michael S Schimmel
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.199

Review 8.  Necrotizing enterocolitis: a multifactorial disease with no cure.

Authors:  Kareena-L Schnabl; John-E Van Aerde; Alan-Br Thomson; Michael-T Clandinin
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

9.  One-dimensional elastic continuum model of enterocyte layer migration.

Authors:  Qi Mi; David Swigon; Béatrice Rivière; Selma Cetin; Yoram Vodovotz; David J Hackam
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

10.  Preclinical neonatal rat studies of heparin-binding EGF-like growth factor in protection of the intestines from necrotizing enterocolitis.

Authors:  Andrei Radulescu; Nicholas A Zorko; Xiaoyi Yu; Gail E Besner
Journal:  Pediatr Res       Date:  2009-04       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.